Skip to Content
Discovering the causes of cancer and the means of prevention

Publication Reprint Request

Title: TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.
Authors: Fagerholm R,  Khan S,  Schmidt MK,  García-Closas M,  Heikkilä P,  Saarela J,  Beesley J,  Jamshidi M,  Aittomäki K,  Liu J,  Ali HR,  Andrulis IL,  Beckmann MW,  Behrens S,  Blows FM,  Brenner H,  Chang-Claude J,  Couch FJ,  Czene K,  Fasching PA,  Figueroa J,  Floris G,  Glendon G,  Guo Q,  Hall P,  Hallberg E,  Hamann U,  Holleczek B,  Hooning MJ,  Hopper JL,  Jager A,  Kabisch M,  kConFab/AOCS Investigators,  Keeman R,  Kosma VM,  Lambrechts D,  Lindblom A,  Mannermaa A,  Margolin S,  Provenzano E,  Shah M,  Southey MC,  Dennis J,  Lush M,  Michailidou K,  Wang Q,  Bolla MK,  Dunning AM,  Easton DF,  Pharoah PD,  Chenevix-Trench G,  Blomqvist C,  Nevanlinna H
Journal: Oncotarget 8(11):18381-18398
Date: 2017 Mar 14
Branches: ITEB, MEB, OD
PubMedID: 28179588

Please tell us where you would like this free reprint sent.
(* = Required fields)

:
:
:
:
:
:
:
:
:
: